ECP 2019 Final Programme

72 Tuesday, 10 Sept ECP 2019 · Nice Two-Day Symposium for Molecular Biologists MD-06 2-Day MD Symposium 10:30–12:00 Clio Mutational signatures and bioinformatics Chairs: Frederick Klauschen, Germany Bastiaan Tops, The Netherlands 001 10:30–11:00 Signal: the homepage of mutational signatures Jan Czarnecki, United Kingdom 002 11:00–11:30 A new user-friendly web application to implement mutational signatures analysis Marcos Diaz-Gay, Spain 003 11:30–12:00 Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy Nadine Gaisa, Germany MD-07 2-Day MD Symposium 14:45–16:45 Clio Immunooncology Chairs: Marjolijn Ligtenberg, The Netherlands Cristina Teixido, Spain 001 14:45–15:15 Multiplexed immunohistochemistry: from translational research to daily practice, is it realistic? Paul Hofman, France 002 15:15–15:40 TMB and mutation testing by TSO500 and FoundationOneCDx in NSCLC Johan Botling, Sweden (supported by Illumina) 003 15:40–16:05 Comparison of TMB testing by Oncomine TML and FMI Carina Heydt, Germany (supported by ThermoFisher) 004 16:05–16:15 Discussion of talk 002 and 003 005 16:15–16:45 Molecular residual disease in early-stage NSCLC: lung TRACERx experience Chris Abosh, United Kingdom (supported by BMS) MD-08 2-Day MD Symposium 17:15–19:15 Clio New technologies Chairs: Erik Jan Dubbink, The Netherlands Carina Heydt, Germany 001 17:15–17:45 Gene fusions in melanoma and/or skin Arnaud de la Fouchardière, France 002 17:45–18:15 NanoString transcript analysis for the detection of gene fusion events Leon van Kempen, The Netherlands 003 18:15–18:45 Proteogenomic tumour profiling Frederick Klauschen, Germany 004 18:45–19:15 Methylation analysis – a new approach to sarcoma classification Andreas von Deimling, Germany